Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

2

Revenue 2017

Novartis

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Novartis' 2013 sales performance.

Novartis

The UK’s new five-year pricing agreement

The UK’s new five-year pricing agreement

Industry leaders who have voiced their support for the deal include Novartis’ UK country president Haseeb Ahmad and EMIG’s chairman Leslie Galloway, who says the ABPI’s negotiating team had ... Haseeb Ahmad, UK country president, Novartis. The

FDA expecting boom in cell and gene therapies

FDA expecting boom in cell and gene therapies for cancer from Novartis and Gilead/Kite Pharma, and there are plenty more in mid- to late-stage development.

Global ban on pharma freebies, including cultural gifts

Global ban on pharma freebies, including cultural gifts Many multinational pharmaceutical companies such as Pfizer, AstraZeneca and Novartis have already instituted global bans on gifts in recent years. ... Last year it emerged that Novartis had made secret payments of millions of dollars to Donald Trump's

HTA guidance from NICE, the SMC and the AWMSG

November 2018:Independent professional body guideline. 9 Jan 2019. Aimovig has a list price of around £5, 000 per year, although Novartis has offered NICE a confidential discount.

GSK upbeat on its return to oncology market

GSK upbeat on its return to oncology market its marketed cancer treatments in the 2015 asset swap with Novartis..

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics